Plus Therapeutics, Inc. (PSTV) SEC Filings — 2025
28 SEC filings for Plus Therapeutics, Inc. (PSTV) in 2025.
Filings
- Plus Therapeutics Relocates Principal Executive Offices — 8-K · Nov 17, 2025
- PSTV Net Loss Widens to $16.7M Amid R&D Cuts, Cash Boosted by Equity Raises — 10-Q · Oct 30, 2025
- PLUS THERAPEUTICS Enters Material Definitive Agreement — 8-K · Oct 21, 2025
- Plus Therapeutics Relocates Principal Executive Offices — 8-K · Aug 26, 2025
- Plus Therapeutics Files 8-K Report — 8-K · Aug 14, 2025
- PSTV Swings to Profit on Derivative Gains, Boosts Liquidity — 10-Q · Aug 14, 2025
- Plus Therapeutics Relocates Principal Executive Offices — 8-K · Aug 13, 2025
- PLUS THERAPEUTICS Files 8-K on Security Holder Vote Matters — 8-K · Aug 12, 2025
- Plus Therapeutics Files Proxy Materials — DEFA14A · Aug 1, 2025
- PLUS THERAPEUTICS Advances Cancer Pipeline, Bolstered by CNSide Acquisition — DEF 14A · Jul 21, 2025
- PLUS THERAPEUTICS FILES 8-K: Accountant Change & Financials — 8-K · Jul 18, 2025
- PLUS THERAPEUTICS, INC. Files 8-K with Material Agreement — 8-K · Jun 20, 2025
- PLUS THERAPEUTICS Files S-1 for Continuous Offering — S-1 · Jun 18, 2025
- PLUS THERAPEUTICS, INC. Files Material Definitive Agreement — 8-K · Jun 17, 2025
- Plus Therapeutics Faces Delisting Concerns — 8-K · Jun 6, 2025
- PLUS THERAPEUTICS Posts $4M Loss, Raises Capital Amid Going Concern Doubts — 10-Q · May 30, 2025
- PLUS THERAPEUTICS, INC. Faces Delisting Concerns — 8-K · May 23, 2025
- Plus Therapeutics Faces Delisting Concerns — 8-K · May 19, 2025
- Plus Therapeutics Files 8-K with Corporate Updates — 8-K · May 2, 2025
- Plus Therapeutics Files Proxy Materials — DEFA14A · May 1, 2025
- Plus Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
- Plus Therapeutics Files 8-K: Board & Compensation Changes — 8-K · Apr 18, 2025
- Plus Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 10, 2025
- Plus Therapeutics Files 2024 10-K, Cites Key Agreements — 10-K · Mar 31, 2025
- Plus Therapeutics Relocates Principal Executive Offices — 8-K · Mar 27, 2025
- PLUS THERAPEUTICS, INC. Files 8-K — 8-K · Mar 10, 2025
- PLUS THERAPEUTICS FILES 8-K: AGREEMENT & EQUITY SALES — 8-K · Mar 4, 2025
- PLUS THERAPEUTICS Files 8-K: Material Agreement, Financial Obligations — 8-K · Feb 18, 2025